Lawmakers grill pharmaceutical executives over drug prices

Health care costs are a major concern for Americans, who spend more on prescription drugs than residents of any other country. On Tuesday, executives from seven of the biggest pharmaceutical companies appeared before a Senate committee to explain their rising prices. They were questioned about R&D spending, patent extensions and their own compensation. John Yang reports on a contentious hearing.